Avanir Pharmaceuticals (AVNR): FQ3 EPS of -$0.11 in-line. Revenue of $10.5M misses by $1.1M. (PR)

|About: Avanir Pharmaceuticals, Inc (AVNR)|By:, SA News Editor
Avanir Pharmaceuticals (AVNR): FQ3 EPS of -$0.11 in-line. Revenue of $10.5M misses by $1.1M. (PR)